Antigen Targeting & Consulting Services Inc. (ATCS Inc) specializes in advanced research and development focused on antigen analysis at the protein level. The company offers a range of services, including antibody humanization, the development of biosimilar antibodies, and immunohistochemistry (IHC) services. Additionally, ATCS provides enzyme-linked immunosorbent assay (ELISA) development and various extra antibody services. Their expertise extends to working with both human and animal cells, offering services such as primary cell culture, cell immortalization, and cell tagging for in vitro and in vivo tracing. The company also emphasizes the development of functional assay platforms for G protein-coupled receptors (GPCRs), showcasing their commitment to cutting-edge technologies in immunology.

ATCS Inc is dedicated to the creation of therapeutic candidates that integrate modern immunological approaches with principles from traditional oriental medicine. This innovative perspective reflects their vision of providing high-quality, custom-based services tailored to the specific needs of their clients. By fostering a creative and ambitious work environment, ATCS encourages its team members to explore novel solutions and methodologies, positioning itself as a forward-thinking entity in the biotechnology industry.

United States

Antigen Targeting & Consulting Service Incorporated (ATCS Inc), a biotech company formed in 2009, is dedicated in providing top-quality custom services for the development of vaccines and immunotherapies. The company specializes in targeting antigens to cell surface molecules on dendritic cells for vaccine development, as well as the development of PSMA-targeted PET imaging agents for improved diagnosis of prostate cancer. ATCS Inc also focuses on the translation of multi-antigen targeted off-the-shelf therapies for various medical conditions.

Antigen Targeting Consulting

Company Details